Tirzepatide is a once weekly injection used to treat Type II Diabetes, shown to help with substantial weight loss
This is fundamentally different from dieting without pharmacological support, where weight regain typically begins within 6 to 12 months and averages 30 to 50 percent of the total loss within two years
If your doctor confirms youve had a serious allergic reaction to Zepbound, they may have you switch to a different treatment

use alternative contraceptive methods during treatment initiation and for 4 weeks after each dose escalation Concomitant medications: Avoid coadministration with other GLP-1 receptor agonists for weight management Patients should be advised to seek medical attention for: Severe, persistent abdominal pain that may radiate to the back (potential pancreatitis) Signs of thyroid tumors including neck mass, dysphagia, dyspnea, or persistent hoarseness Symptoms of acute gallbladder disease (right upper quadrant pain, fever, jaundice) Severe gastrointestinal symptoms leading to dehydration Changes in vision or signs of hypoglycemia Signs of hypersensitivity reactions including rash, itching, or difficulty breathing Clinicians should conduct a thorough medical history before initiating tirzepatide, including assessment for personal or family history of medullary thyroid carcinoma or MEN 2, history of pancreatitis, severe gastrointestinal disease, and diabetic retinopathy